Do age and comorbidity affect intensity of pharmacological therapy for poorly controlled diabetes mellitus?

J Am Geriatr Soc. 2005 Jul;53(7):1214-6. doi: 10.1111/j.1532-5415.2005.53370.x.

Abstract

Objectives: To examine the influence of age and comorbidity on intensification of medical therapy for patients with poorly controlled diabetes mellitus (DM).

Design: Observational cohort study using data from Department of Veterans Affairs (VA) national databases.

Setting: Thirteen VA medical centers in New England, Florida, and Puerto Rico.

Participants: Veterans (N=5,317) with poorly controlled DM receiving regular medical care

Measurements: An increase in hypoglycemic medications, or intensification of therapy, was considered present at the visit if a new hypoglycemic medication was started or the dosage of an existing medication was increased.

Results: The overall rate of intensification of therapy was 20.8% (1,106/5,317). The rate of intensification was highest in the youngest patients without comorbidity (24.5%) and lowest in the oldest patients with comorbidity (15.7%) (P<.001).

Conclusion: Rates of intensification at a single clinic visit were quite low in all groups and were lowest in older patients with comorbidity.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Cohort Studies
  • Diabetes Complications*
  • Diabetes Mellitus / drug therapy*
  • Female
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Male
  • Middle Aged

Substances

  • Hypoglycemic Agents